The FDA has requested the Parkinson’s disease drug Permax to be pulled from the market after studies showed Permax has been linked to heart valve damage and increased risk of heart attack.
At least 14 patients have needed to have heart valves replaced, but an FDA official says be believes that number to be higher.
Patients are being told not to stop using the drug abruptly, and to consult with their doctor about either a switch to another drug or about a gradual reduction in the amount of pergolide.
The agency’s official estimates that over 12,000 people use Permax to treat symptoms of Parkinson’s
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.